[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Lung Cancer Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

March 2024 | 93 pages | ID: L4E972DA6A05EN
Prof Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report describes the global market size of Lung Cancer Drugs from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For geography segment, regional supply, demand, major players, price is presented from 2019 to 2029. This report cover following regions:
North America
South America
Asia & Pacific
Europe
MEA

The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For competitor segment, the report include global key players of Lung Cancer Drugs as well as some small players. The information for each competitor include:
Company Profile
Business Information
SWOT Analysis
Revenue, Gross Margin and Market Share

Types Segment:
cemiplimab
pembrolizumab
nivolumab
atezolizumab
durvalumab
avelumab
Others

Companies Covered:
Regeneron Pharmaceuticals/Sanofi
Merck
Bristol-Myers Squibb
Roche
AstraZeneca
Pfizer
etc.

Please ask for sample pages for full companies list

Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029

Any special requirements about this report, please let us know and we can provide custom report.
CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Sources
  3.2.1 Data Sources
  3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 Lung Cancer Drugs Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 HISTORICAL AND FORECAST LUNG CANCER DRUGS MARKET IN NORTH AMERICA (2019-2029)

8.1 Lung Cancer Drugs Market Size
8.2 Lung Cancer Drugs Market by End Use
8.3 Competition by Players/Suppliers
8.4 Lung Cancer Drugs Market Size by Type
8.5 Key Countries Analysis
  8.5.1 United States
  8.5.2 Canada
  8.5.3 Mexico

CHAPTER 9 HISTORICAL AND FORECAST LUNG CANCER DRUGS MARKET IN SOUTH AMERICA (2019-2029)

9.1 Lung Cancer Drugs Market Size
9.2 Lung Cancer Drugs Market by End Use
9.3 Competition by Players/Suppliers
9.4 Lung Cancer Drugs Market Size by Type
9.5 Key Countries Analysis
  9.5.1 Brazil
  9.5.2 Argentina
  9.5.3 Chile
  9.5.4 Peru

CHAPTER 10 HISTORICAL AND FORECAST LUNG CANCER DRUGS MARKET IN ASIA & PACIFIC (2019-2029)

10.1 Lung Cancer Drugs Market Size
10.2 Lung Cancer Drugs Market by End Use
10.3 Competition by Players/Suppliers
10.4 Lung Cancer Drugs Market Size by Type
10.5 Key Countries Analysis
  10.5.1 China
  10.5.2 India
  10.5.3 Japan
  10.5.4 South Korea
  10.5.5 Southest Asia
  10.5.6 Australia

CHAPTER 11 HISTORICAL AND FORECAST LUNG CANCER DRUGS MARKET IN EUROPE (2019-2029)

11.1 Lung Cancer Drugs Market Size
11.2 Lung Cancer Drugs Market by End Use
11.3 Competition by Players/Suppliers
11.4 Lung Cancer Drugs Market Size by Type
11.5 Key Countries Analysis
  11.5.1 Germany
  11.5.2 France
  11.5.3 United Kingdom
  11.5.4 Italy
  11.5.5 Spain
  11.5.6 Belgium
  11.5.7 Netherlands
  11.5.8 Austria
  11.5.9 Poland
  11.5.10 Russia

CHAPTER 12 HISTORICAL AND FORECAST LUNG CANCER DRUGS MARKET IN MEA (2019-2029)

12.1 Lung Cancer Drugs Market Size
12.2 Lung Cancer Drugs Market by End Use
12.3 Competition by Players/Suppliers
12.4 Lung Cancer Drugs Market Size by Type
12.5 Key Countries Analysis
  12.5.1 Egypt
  12.5.2 Israel
  12.5.3 South Africa
  12.5.4 Gulf Cooperation Council Countries
  12.5.5 Turkey

CHAPTER 13 SUMMARY FOR GLOBAL LUNG CANCER DRUGS MARKET (2019-2024)

13.1 Lung Cancer Drugs Market Size
13.2 Lung Cancer Drugs Market by End Use
13.3 Competition by Players/Suppliers
13.4 Lung Cancer Drugs Market Size by Type

CHAPTER 14 GLOBAL LUNG CANCER DRUGS MARKET FORECAST (2024-2029)

14.1 Lung Cancer Drugs Market Size Forecast
14.2 Lung Cancer Drugs Application Forecast
14.3 Competition by Players/Suppliers
14.4 Lung Cancer Drugs Type Forecast

CHAPTER 15 ANALYSIS OF GLOBAL KEY VENDORS

15.1 Regeneron Pharmaceuticals/Sanofi
  15.1.1 Company Profile
  15.1.2 Main Business and Lung Cancer Drugs Information
  15.1.3 SWOT Analysis of Regeneron Pharmaceuticals/Sanofi
  15.1.4 Regeneron Pharmaceuticals/Sanofi Lung Cancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.2 Merck
  15.2.1 Company Profile
  15.2.2 Main Business and Lung Cancer Drugs Information
  15.2.3 SWOT Analysis of Merck
  15.2.4 Merck Lung Cancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.3 Bristol-Myers Squibb
  15.3.1 Company Profile
  15.3.2 Main Business and Lung Cancer Drugs Information
  15.3.3 SWOT Analysis of Bristol-Myers Squibb
  15.3.4 Bristol-Myers Squibb Lung Cancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.4 Roche
  15.4.1 Company Profile
  15.4.2 Main Business and Lung Cancer Drugs Information
  15.4.3 SWOT Analysis of Roche
  15.4.4 Roche Lung Cancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.5 AstraZeneca
  15.5.1 Company Profile
  15.5.2 Main Business and Lung Cancer Drugs Information
  15.5.3 SWOT Analysis of AstraZeneca
  15.5.4 AstraZeneca Lung Cancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.6 Pfizer
  15.6.1 Company Profile
  15.6.2 Main Business and Lung Cancer Drugs Information
  15.6.3 SWOT Analysis of Pfizer
  15.6.4 Pfizer Lung Cancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
Please ask for sample pages for full companies list

LIST OF TABLES AND FIGURES

Table Abbreviation and Acronyms
Table Research Scope of Lung Cancer Drugs Report
Table Data Sources of Lung Cancer Drugs Report
Table Major Assumptions of Lung Cancer Drugs Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Lung Cancer Drugs Picture
Table Lung Cancer Drugs Classification
Table Lung Cancer Drugs Applications
Table Drivers of Lung Cancer Drugs Market
Table Restraints of Lung Cancer Drugs Market
Table Opportunities of Lung Cancer Drugs Market
Table Threats of Lung Cancer Drugs Market
Table Covid-19 Impact For Lung Cancer Drugs Market
Table Raw Materials Suppliers
Table Different Production Methods of Lung Cancer Drugs
Table Cost Structure Analysis of Lung Cancer Drugs
Table Key End Users
Table Latest News of Lung Cancer Drugs Market
Table Merger and Acquisition
Table Planned/Future Project of Lung Cancer Drugs Market
Table Policy of Lung Cancer Drugs Market
Table 2019-2029 North America Lung Cancer Drugs Market Size
Figure 2019-2029 North America Lung Cancer Drugs Market Size and CAGR
Table 2019-2029 North America Lung Cancer Drugs Market Size by Application
Table 2019-2024 North America Lung Cancer Drugs Key Players Revenue
Table 2019-2024 North America Lung Cancer Drugs Key Players Market Share
Table 2019-2029 North America Lung Cancer Drugs Market Size by Type
Table 2019-2029 United States Lung Cancer Drugs Market Size
Table 2019-2029 Canada Lung Cancer Drugs Market Size
Table 2019-2029 Mexico Lung Cancer Drugs Market Size
Table 2019-2029 South America Lung Cancer Drugs Market Size
Figure 2019-2029 South America Lung Cancer Drugs Market Size and CAGR
Table 2019-2029 South America Lung Cancer Drugs Market Size by Application
Table 2019-2024 South America Lung Cancer Drugs Key Players Revenue
Table 2019-2024 South America Lung Cancer Drugs Key Players Market Share
Table 2019-2029 South America Lung Cancer Drugs Market Size by Type
Table 2019-2029 Brazil Lung Cancer Drugs Market Size
Table 2019-2029 Argentina Lung Cancer Drugs Market Size
Table 2019-2029 Chile Lung Cancer Drugs Market Size
Table 2019-2029 Peru Lung Cancer Drugs Market Size
Table 2019-2029 Asia & Pacific Lung Cancer Drugs Market Size
Figure 2019-2029 Asia & Pacific Lung Cancer Drugs Market Size and CAGR
Table 2019-2029 Asia & Pacific Lung Cancer Drugs Market Size by Application
Table 2019-2024 Asia & Pacific Lung Cancer Drugs Key Players Revenue
Table 2019-2024 Asia & Pacific Lung Cancer Drugs Key Players Market Share
Table 2019-2029 Asia & Pacific Lung Cancer Drugs Market Size by Type
Table 2019-2029 China Lung Cancer Drugs Market Size
Table 2019-2029 India Lung Cancer Drugs Market Size
Table 2019-2029 Japan Lung Cancer Drugs Market Size
Table 2019-2029 South Korea Lung Cancer Drugs Market Size
Table 2019-2029 Southeast Asia Lung Cancer Drugs Market Size
Table 2019-2029 Australia Lung Cancer Drugs Market Size
Table 2019-2029 Europe Lung Cancer Drugs Market Size
Figure 2019-2029 Europe Lung Cancer Drugs Market Size and CAGR
Table 2019-2029 Europe Lung Cancer Drugs Market Size by Application
Table 2019-2024 Europe Lung Cancer Drugs Key Players Revenue
Table 2019-2024 Europe Lung Cancer Drugs Key Players Market Share
Table 2019-2029 Europe Lung Cancer Drugs Market Size by Type
Table 2019-2029 Germany Lung Cancer Drugs Market Size
Table 2019-2029 France Lung Cancer Drugs Market Size
Table 2019-2029 United Kingdom Lung Cancer Drugs Market Size
Table 2019-2029 Italy Lung Cancer Drugs Market Size
Table 2019-2029 Spain Lung Cancer Drugs Market Size
Table 2019-2029 Belgium Lung Cancer Drugs Market Size
Table 2019-2029 Netherlands Lung Cancer Drugs Market Size
Table 2019-2029 Austria Lung Cancer Drugs Market Size
Table 2019-2029 Poland Lung Cancer Drugs Market Size
Table 2019-2029 Russia Lung Cancer Drugs Market Size
Table 2019-2029 MEA Lung Cancer Drugs Market Size
Figure 2019-2029 MEA Lung Cancer Drugs Market Size and CAGR
Table 2019-2029 MEA Lung Cancer Drugs Market Size by Application
Table 2019-2024 MEA Lung Cancer Drugs Key Players Revenue
Table 2019-2024 MEA Lung Cancer Drugs Key Players Market Share
Table 2019-2029 MEA Lung Cancer Drugs Market Size by Type
Table 2019-2029 Egypt Lung Cancer Drugs Market Size
Table 2019-2029 Israel Lung Cancer Drugs Market Size
Table 2019-2029 South Africa Lung Cancer Drugs Market Size
Table 2019-2029 Gulf Cooperation Council Countries Lung Cancer Drugs Market Size
Table 2019-2029 Turkey Lung Cancer Drugs Market Size
Table 2019-2024 Global Lung Cancer Drugs Market Size by Region
Table 2019-2024 Global Lung Cancer Drugs Market Size Share by Region
Table 2019-2024 Global Lung Cancer Drugs Market Size by Application
Table 2019-2024 Global Lung Cancer Drugs Market Share by Application
Table 2019-2024 Global Lung Cancer Drugs Key Vendors Revenue
Figure 2019-2024 Global Lung Cancer Drugs Market Size and Growth Rate
Table 2019-2024 Global Lung Cancer Drugs Key Vendors Market Share
Table 2019-2024 Global Lung Cancer Drugs Market Size by Type
Table 2019-2024 Global Lung Cancer Drugs Market Share by Type
Table 2024-2029 Global Lung Cancer Drugs Market Size by Region
Table 2024-2029 Global Lung Cancer Drugs Market Size Share by Region
Table 2024-2029 Global Lung Cancer Drugs Market Size by Application
Table 2024-2029 Global Lung Cancer Drugs Market Share by Application
Table 2024-2029 Global Lung Cancer Drugs Key Vendors Revenue
Figure 2024-2029 Global Lung Cancer Drugs Market Size and Growth Rate
Table 2024-2029 Global Lung Cancer Drugs Key Vendors Market Share
Table 2024-2029 Global Lung Cancer Drugs Market Size by Type
Table 2024-2029 Lung Cancer Drugs Global Market Share by Type


More Publications